WAYNE STATE UNIVERSITY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 104152
 
  
 
C07D HETEROCYCLIC COMPOUNDS 45117
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 38168
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 32135
 
  
 
C07K PEPTIDES 24112
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 22103
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 16138
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 1456
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1386
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 12126

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0074,180 ULTRAFAST TARGET DETECTION BASED ON MICROWAVE METAMATERIALSFeb 26, 16Mar 15, 18[H04B, G01S]
2018/0068,577 AUGMENTED REALITY SYSTEM AND METHOD FOR EXPOSURE THERAPY AND MOTOR SKILLS TRAININGSep 08, 16Mar 08, 18[G09B, H04N, G06T, G06F]
2018/0037,865 METHODS AND COMPOSITIONS RELATING TO TREATMENT OF NERVOUS SYSTEM INJURIESAug 07, 17Feb 08, 18[A61K, C12N]
2018/0028,608 COMPOSITIONS AND METHODS TO DIAGNOSE DIABETES AND/OR TO TREAT NEGATIVE EFFECTS OF DIABETESAug 08, 17Feb 01, 18[A61K, C12Q]
2018/0031,565 DETECTORS OF SERUM BIOMARKERS FOR PREDICTING OVARIAN CANCER RECURRENCEOct 17, 17Feb 01, 18[G01N, C07K]
2018/0021,315 METHODS OF TREATING HEARING DISORDERSJul 20, 17Jan 25, 18[A61K]
2018/0015,198 METHOD OF MAKING INJECTABLE CEMENTSFeb 08, 16Jan 18, 18[A61L]
2018/0012,745 MASS SPECTROMETRY USING LASERSPRAY IONIZATIONJul 19, 17Jan 11, 18[H01J]
2017/0363,612 COMPOSITIONS AND METHODS RELATING TO PROLIFERATIVE DISORDERSDec 03, 15Dec 21, 17[A61K, C12Q, C12N, G01N]
2017/0356,043 ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAMEAug 23, 17Dec 14, 17[C12Q, C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9911974 Composite anode for lithium ion batteriesOct 12, 12Mar 06, 18[H01M]
9822446 Thermally stable volatile precursorsFeb 05, 16Nov 21, 17[C23C, C07F]
9824872 Systems and methods for high throughput solvent assisted ionization inlet for mass spectrometryJun 13, 16Nov 21, 17[H01J]
9816076 Protein-induced pluripotent cell technology and uses thereofMay 02, 12Nov 14, 17[C12N]
9797906 Detectors of serum biomarkers for predicting ovarian cancer recurrenceMay 06, 13Oct 24, 17[G01N, C07K]
9790435 Green diesel production from hydrothermal catalytic decarboxylation on a supported Pd—Co catalystJun 19, 15Oct 17, 17[C10L, B01J, C10G]
9776177 Bimetal catalystsMar 28, 13Oct 03, 17[B01J, C10G]
9778105 Static interferometer with step-style reflective elementOct 20, 14Oct 03, 17[G01J, G02B]
9758866 Synthesis and characterization of first row transition metal complexes containing α-imino alkoxides as precursors for deposition of metal filmsFeb 13, 13Sep 12, 17[C23C, C07F]
9730888 Method of enhancing delivery of therapeutic compounds to the eyeMar 13, 14Aug 15, 17[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0216,445 CXCR4 INHIBITING CARRIERS FOR NUCLEIC ACID DELIVERYAbandonedJan 11, 17Aug 03, 17[A61K, C08G]
2017/0015,672 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES FOR SELECTIVELY TARGETING TUMOR CELLS WITH FR-ALPHA AND FR-BETA TYPE RECEPTORSAbandonedSep 29, 16Jan 19, 17[C07D]
2016/0310,572 COMPOSITIONS AND METHODS TO DIAGNOSE DIABETES AND/OR TO TREAT NEGATIVE EFFECTS OF DIABETESAbandonedDec 02, 14Oct 27, 16[A61K, C12Q]
2016/0211,126 MASS SPECTROMETRY USING LASERSPRAY IONIZATIONAbandonedOct 20, 15Jul 21, 16[H01J]
2016/0074,401 COMPOSITIONS AND METHODS UTILIZING PHOSPHODIESTERASE INHIBITORS TO TREAT BLAST-INDUCED TINNITUS AND/OR HEARING LOSSAbandonedApr 17, 14Mar 17, 16[A61K]
2016/0068,503 (-)-EPIGALLOCATECHIN GALLATE DERIVATIVES FOR INHIBITING PROTEASOMEAbandonedSep 15, 15Mar 10, 16[C07D]
2015/0377,889 GALECTIN-3 AS A MARKER FOR PROSTATE CANCERAbandonedFeb 14, 14Dec 31, 15[G01N]
2015/0355,183 NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYSAbandonedJul 25, 11Dec 10, 15[G01N]
2015/0337,350 AUTOMATED VIABILITY TESTING SYSTEMAbandonedJun 21, 13Nov 26, 15[C12Q, G01N, C02F, B01D]
2015/0335,719 Intravitreal Injection of a Chimeric Phage Endolysin Ply187; Protection from Staphylococcus aureus EndophthalmitisAbandonedMay 23, 14Nov 26, 15[A61K]
2015/0307,937 ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAMEAbandonedAug 22, 13Oct 29, 15[C12Q, C12N]
2015/0197,068 METHOD OF MAKING COMPOSITE MATERIALSAbandonedJul 10, 13Jul 16, 15[B32B]
2015/0089,870 POPULATION CONTROL OF INVASIVE PLANT SPECIES AND RESTORATION OF NATIVE PLANT COMMUNITIESAbandonedOct 01, 14Apr 02, 15[A01N, C12N, A01G]
2015/0053,178 COMBUSTION MODIFICATION AND EMISSIONS REDUCTION UTILIZING AN ELECTRICALLY INSULATED ENGINE MEMBER IN INTERNAL COMBUSTION ENGINESAbandonedMar 28, 13Feb 26, 15[F02P]
2015/0038,378 BIOCOMPATIBLE GRAPHENE SENSORAbandonedFeb 16, 12Feb 05, 15[G01N, A61B]
2015/0039,141 SYSTEM AND METHOD USING FUZZY LOGIC FOR RESOURCE CONSERVATIONAbandonedJul 30, 14Feb 05, 15[G06N, H02J, H05B, G06Q, G05D]
2014/0378,541 Synthetic Epigallocatechin Gallate (EGCG) AnalogsAbandonedJun 15, 12Dec 25, 14[A61K, C12N, C07C]
2014/0349,889 FORMATION OF A SUPRA-MONOLAYER NANOPATTERN AND ITS USESAbandonedDec 11, 12Nov 27, 14[C23C, B01J]
2014/0205,538 VACCINES TARGETING CELLULAR DEATH RECEPTORSAbandonedJan 15, 14Jul 24, 14[A61K]
2014/0183,669 RESONANT SENSOR WITH ASYMMETRIC GAPPED CANTILEVERSAbandonedMar 25, 11Jul 03, 14[B81C, B81B]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.